Abstract
Prevention of peritoneal recurrence of gastric cancer The peritoneal cavity is the main site of gastric cancer recurrence after curative surgery. When this re currence occurs, patients may experience bowel obstruction, dehydration and multiple hospital admissions. The therapeutic options that may decrease the rate of peritoneal recurrence and increase five years survival are intraoperative hyperthermic chemotherapy, extensive intraoperative peritoneal lavage and routine bursectomy. We herein review the oncological results of curative surgery for gastric cancer, its failure patterns and the risk factors for peritoneal recurrence. We also review the studies aiming to prevent peritoneal carcinomatosis.
Highlights
The peritoneal cavity is the main site of gastric cancer recurrence after curative surgery
Por lo que es más lógico pensar en tratamientos adyuvantes a través de la cavidad peritoneal, en que el paso de la quimioterapia a la circulación sistémica sea mínimo
Mi DH, Li Z, Yang KH, Cao N, Lethaby A, Tian JH, et al Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trial
Summary
PREVENCIÓN DE LA RECURRENCIA PERITONEAL EN EL TRATAMIENTO QUIRÚRGICO DEL CÁNCER GÁSTRICO*. Drs Marco Ceroni V.1, Eduardo Viñuela F.1, Enrique Norero M.1, Nicolás Jarufe C.1, Fernando Crovari E.1, Alex Escalona P.1, Allan Sharp P.1, Eduardo Briceño V.1, Cristian Martínez B., Alfonso Díaz F.1, Luis Ibáñez A.1
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
